Management of bleeding in acquired hemophilia A: Results from the European Acquired Haemophilia (EACH2) registry

Blood

Volumn 120, Issue 1, 2012, Pages 39-46

  Baudo, Francesco ^a   Collins, Peter ^b   Huth Kühne, Angela ^c   Lévesque, Hervé ^d   Marco, Pascual ^e   Nemes, László ^f   Pellegrini, Fabio ^g   Tengborn, Lilian ^h   Knoebl, Paul ⁱ  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c Hemophilia Center   (Germany)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^f State Health Center   (Hungary)

^g Santa Maria Imbaro   (Italy)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACQUIRED HEMOPHILIA A; ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL PRACTICE; DISEASE REGISTRY; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSAL BLEEDING; MUSCLE BLEEDING; PALLIATIVE THERAPY; PRIORITY JOURNAL; SKIN BLEEDING; THROMBOSIS;

EID: 84863538387     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-408930     Document Type: Article

References (36)

1. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost. 1981;45(3):200-203. (Pubitemid 11081028)
2. Baudo F, de Cataldo F. Acquired hemophilia: a critical bleeding syndrome. Haematologica. 2004;89(1):96-100. (Pubitemid 38165860)
3. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007;109(5):1870-1877. (Pubitemid 46348182)
4. Baudo F, Mostarda G, de Cataldo F. Acquired factor VIII and factor IX inhibitors: survey of the Italian haemophila centers (AICE). Haematologica. 2003;88(Suppl 12):93-99.
5. Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood. 2008;112(2):250-255.
6. Baudo F, de Cataldo F. Acquired haemophilia in the elderly. In: Balducci L, ErshlerW, de Gaetano G, eds. Blood Disorders in the Elderly. Cambridge, United Kingdom: Cambridge University Press; 2007:389-407.
7. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost. 1997;78(6):1463-1467. (Pubitemid 27519390)
8. Sallah S, Aledort L. Treatment of patients with acquired inhibitors. J Thromb Haemost. 2005;3(3):595-597.
9. Sumner MJ, Geldziler BD, Pedersen M, Seremetis S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia. 2007;13(5):451-461. (Pubitemid 47337982)
10. Huth-Kühne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009;94(4):566-575.
11. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006;133(6):591-605. (Pubitemid 43742773)
12. Gringeri A, Mannucci PM. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia. 2005;11(6):611-619. (Pubitemid 41631596)
13. Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10(4):622-631.
14. Collins P, Baudo F, Knöbl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia registry (EACH2). Blood. 2012;120(1):47-55.
15. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. Cary, NC: SAS Institute, 2004.
16. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
17. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics. 1998;54(3):948-963. (Pubitemid 28429289)
18. Kurczynski EM, Penner JA. Activated prothrombin concentrate for patients with factor VIII inhibitors. N Engl J Med. 1974;291(4):164-167.
19. Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia: a natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med. 1987;147(6):1077-1081. (Pubitemid 17113272)
20. Grünewald M, Beneke H, Guthner C, Germowitz A, Brommer A, Griesshammer M. Acquired haemophilia: experiences with a standardized approach. Haemophilia. 2001;7(2):164-169. (Pubitemid 32243799)
21. Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80(1):55-63. (Pubitemid 41254270)
22. Green D. The management of acquired haemophilia. Haemophilia. 2006;12(Suppl 5):32-36. (Pubitemid 44615002)
23. Kessler CM. New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program. 2005;2005:429-435.
24. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol. 2003;121(1):21-35. (Pubitemid 36461264)
25. Holme PA, Brosstad F, Tjonnfjord GE. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia. 2005;11(5):510-515. (Pubitemid 41283121)
26. Goudemand J. Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: the French experience. Haemophilia. 2004;10(Suppl 3):68-72. Abstract 14 P014.
27. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia. 2004;10(2):169-173. (Pubitemid 38312644)
28. Astermark J, Donfield SM, DiMichele DM, et al. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2007;109(2):546-551. (Pubitemid 46105952)
29. Young G, Shafer FE, Rojas P, Seremetis S. Single 270 microg kg(-1)-dose rFVIIa vs standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison. Haemophilia. 2008;14(2):287-294. (Pubitemid 351338689)
30. Aledort LM. Factor VIII inhibitor bypassing activity (FEIBA): addressing safety issues. Haemophilia. 2008;14(1):39-43.
31. Abshire T, Kenet G. Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors. Haemophilia. 2008;14(5):898-902.
32. Huth-Kühne A, International Expert Panel on Acquired Hemophilia. Cautions and caveats to the treatment of acquired hemophilia A. Haematologica. 2009;94(8):1181-1182.
33. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134(5):1128-1135.
34. Macchia A, Monte S, Pellegrini F, et al. Depression worsens outcomes in elderly patients with heart failure: an analysis of 48,117 patients in a community setting. Eur J Heart Fail. 2008;10(7):714-721.
35. Tritapepe L, De Santis V, Vitale D, et al. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis. Crit Care Med. 2007;35(7):1685-1690. (Pubitemid 46985870)
36. Trojano M, Pellegrini F, Paolicelli D, et al. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. Ann Neurol. 2009;66(4):513-520.